Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohd Ishaq Dar

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|December 21, 2020
Targeting EHMT2/ G9a for cancer therapy: Progress and perspectiveSuraya Jan, Mohd Ishaq Dar, Rubiada Wani, et al.
European Journal of Pharmacology|June 17, 2019
Rottlerin is a pan phosphodiesterase inhibitor and can induce neurodifferentiation in IMR-32 human neuroblastoma cellsMohd Ishaq Dar, Priya Mahajan, Suraya Jan, et al.
Chemistry & Biodiversity|March 14, 2023
Pyrazolopyrimidinone Based Selective Inhibitors of PDE5 for the Treatment of Erectile DysfunctionAbhinandan D Hudwekar, Pankul Kotwal, Mohd Ishaq Dar, et al.
Bioorganic Chemistry|June 11, 2019
Design, synthesis and biological evaluation of pyrazolopyrimidinone based potent and selective PDE5 inhibitors for treatment of erectile dysfunctionG Lakshma Reddy, Mohd Ishaq Dar, Abhinandan D Hudwekar, et al.
Bioorganic & Medicinal Chemistry|March 25, 2015
Discovery of novel pyrazolopyrimidinone analogs as potent inhibitors of phosphodiesterase type-5Sanghapal D Sawant, G Lakshma Reddy, Mohd Ishaq Dar, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|December 21, 2020
Targeting EHMT2/ G9a for cancer therapy: Progress and perspectiveSuraya Jan, Mohd Ishaq Dar, Rubiada Wani, et al.
European Journal of Pharmacology|June 17, 2019
Rottlerin is a pan phosphodiesterase inhibitor and can induce neurodifferentiation in IMR-32 human neuroblastoma cellsMohd Ishaq Dar, Priya Mahajan, Suraya Jan, et al.
Chemistry & Biodiversity|March 14, 2023
Pyrazolopyrimidinone Based Selective Inhibitors of PDE5 for the Treatment of Erectile DysfunctionAbhinandan D Hudwekar, Pankul Kotwal, Mohd Ishaq Dar, et al.
Bioorganic Chemistry|June 11, 2019
Design, synthesis and biological evaluation of pyrazolopyrimidinone based potent and selective PDE5 inhibitors for treatment of erectile dysfunctionG Lakshma Reddy, Mohd Ishaq Dar, Abhinandan D Hudwekar, et al.
Bioorganic & Medicinal Chemistry|March 25, 2015
Discovery of novel pyrazolopyrimidinone analogs as potent inhibitors of phosphodiesterase type-5Sanghapal D Sawant, G Lakshma Reddy, Mohd Ishaq Dar, et al.
Pageof 1